Carle Cancer Institute Normal LLC (EIN 371363717) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1996

Legal Domicile

Phone

2173833311

Tax Period

2022-01-01 to 2022-10-14

Carle Cancer Institute Normal LLC, founded in 1996, is a small nonprofit that reported $308K in total revenue in fiscal year 2022. Revenue fell 95% from the prior year — a significant decline worth monitoring. The organization ran a surplus of $231K, a strong 75% operating margin.

Mission

TO BE THE DESTINATION OF CHOICE FOR CANCER TREATMENT SERVICES IN THE EASTERN REGION OF CENTRAL ILLINOIS THROUGH EFFECTIVE PARTNERSHIPS COUPLED WITH PERSONALIZED CARE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2022)

Revenue Breakdown

Contributions & Grants $126,115

Program Service Revenue $180,966

Investment Income $0

Other Revenue $995

TOTAL REVENUE $308,076

Expense Breakdown

Grants Paid $0

Salaries & Benefits $6,151

Fundraising Expenses $0

Program Expenses $7,662

Other Expenses $70,510

TOTAL EXPENSES $76,661

Year-over-Year Comparison

	2022	2021	Change
Revenue	$308,076	$5,871,210	-0.9%
Expenses	$76,661	$6,347,095	-1.0%
Net Income	$231,415	$-475,885	-1.5%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$8,968,084

Total Directors

$3,340,545

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
N/A	President	1.0	Officer Director	$0	$230,450	$933,296
N/A	Secretary & Treasurer of Board	1.0	Officer Director	$0	$95,256	$443,993
N/A	Vice Chair	1.0	Officer Director	$0	$51,663	$1,330,526
N/A	Manager & Trustee/Director	1.0	Director	$0	$68,434	$632,730
N/A	Exec VP, Chief Finance & Strategy Officer	0.5	Officer	$0	$414,800	$1,700,899
N/A	Ex-Officio, President & CEO	0.5	Officer	$0	$661,809	$2,801,918
N/A	Exec VP & Chief Operating Officer	0.5	Officer	$0	$394,190	$1,757,452
N/A	Former - Chair	0.0		$0	$9,676	$175,590
N/A	Former - Key Employee	0.0		$0	$15,803	$206,020
N/A	Former - Key Employee	0.0		$0	$72,453	$490,663

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2022	$308,076	$76,661	No data	$231,415
2021	$5,871,210	$6,347,095	$1,112,312	$-475,885
2020	$8,059,814	$8,204,870	$3,644,020	$-145,056
2019	$9,031,921	$9,465,964	$3,390,605	$-434,043
2018	$9,100,105	$10,558,679	$3,916,038	$-1,458,574

Carle Cancer Institute Normal LLC